TrialPath
Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

NCT07218146 · Zai Lab (Hong Kong), Ltd.
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants With Relapsed Small Cell Lung Cancer
About this study
The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer.
Eligibility criteria
Inclusion Criteria: * Age \>/= 18 years, or considered an adult by local regulations, at the time of consent * Signed informed consent * Histologically or cytologically confirmed SCLC. Received 1L platinum-based systemic therapy and had documented disease progression during or after the most recent systemic therapy. Or received 2L tarlatamab is allowed. * Measurable disease according to RECIST v1.1 as assessed by the investigator. * Participants with a history of treated and stable or untreated and asymptomatic CNS metastases based on criteria per protocol. * Adequate organ and marrow function * Eastern Cooperative Group (ECOG) performance status of 0 or 1 * Life expectancy of at least 3 months * Participants must be willing to undergo a tumor biopsy or provide archived tumor tissue sample at Screening * Participants must be willing and able to comply with protocol for the duration of the study Exclusion Criteria: * Received more than one line of systemic therapy for Extensive-Stage SCLC. * Received any prior ADC with topoisomerase 1 inhibitor payload * Participants with another known malignancy with exceptions defined in the protocol. * History or suspected ILD/pneumonitis based on criteria per protocol * Clinically severe pulmonary compromise resulting from intercurrent pulmonary illnesses. * Receipt of anti-cancer treatment known to treat cancers within 3 weeks before the first dose of study treatment. * Prior radiotherapy before study treatment based on criteria per protocol * Unresolved toxicity of Grade \>/= 2 from previous anti-cancer treatment, except for alopecia and skin pigmentation. * Known infection or active infection defined in the protocol. * Clinically significant active cardiovascular disease or history of arterial thromboembolic event within 6 months prior to the first dose of study treatment based on criteria per protocol.
Study design
Enrollment target: 480 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2025-11-30
Estimated completion: 2028-11-30
Last updated: 2026-10-16
Interventions
Drug: ZL-1310Drug: Investigator's Choice of Therapy
Primary outcomes
  • • Confirmed objective response rate (ORR) assessed by Blinded Independent Central Review of ZL-1310 compared to Investigator's Choice Therapy (ICT) (up to 30 months)
  • • Overall survival of ZL-1310 compared to Investigator's Choice Therapy (ICT) (up to 30 months)
Sponsor
Zai Lab (Shanghai) Co., Ltd. · industry
With: Zai Lab (US) LLC
Contacts & investigators
ContactZL-1310-003 Study Team · contact · study-ZL-1310-003@zailaboratory.com · 650-360-1601
All locations (165)
University of California San DiegoRecruiting
La Jolla, California, United States
UC Davis Comprehensive Cancer CenterRecruiting
Sacramento, California, United States
University of ColoradoRecruiting
Aurora, Colorado, United States
Yale Cancer Center/Clinical Trials OfficeRecruiting
New Haven, Connecticut, United States
Clermont Oncology CenterRecruiting
Clermont, Florida, United States
Mid Florida Hematology and Oncology CenterRecruiting
Orange City, Florida, United States
Cancer Centers of BevardRecruiting
Rockledge, Florida, United States
Sarah Cannon Research InstituteRecruiting
Sarasota, Florida, United States
Florida Cancer Specialists - NorthRecruiting
St. Petersburg, Florida, United States
Moffitt Cancer CenterRecruiting
Tampa, Florida, United States
Florida Cancer Specialists - EastRecruiting
West Palm Beach, Florida, United States
Illinois Cancer CareRecruiting
Peoria, Illinois, United States
OSF St. Francis Medical CenterRecruiting
Peoria, Illinois, United States
University of IowaRecruiting
Iowa City, Iowa, United States
University of Iowa Mission Health Cancer + BloodRecruiting
Waukee, Iowa, United States
Norton Cancer InstituteRecruiting
Louisville, Kentucky, United States
American Oncology Partners, PA - The Center for Cancer and Blood DisordersRecruiting
Bethesda, Maryland, United States
Maryland Oncology HematologyRecruiting
Silver Spring, Maryland, United States
Henry Ford Health CancerRecruiting
Detroit, Michigan, United States
Missouri Cancer AssociatesRecruiting
Columbia, Missouri, United States
Mercy SouthRecruiting
St Louis, Missouri, United States
Stony Brook Cancer CenterRecruiting
Stony Brook, New York, United States
Montefiore Medical CenterRecruiting
The Bronx, New York, United States
Cleveland Clinic - Akron General Medical CenterRecruiting
Akron, Ohio, United States
University Hospitals Cleveland Medical CenterRecruiting
Cleveland, Ohio, United States
Cleveland Clinic - Fairview Hospital Molly PavilionRecruiting
Cleveland, Ohio, United States
Cleveland ClinicRecruiting
Cleveland, Ohio, United States
Cleveland Clinic - Hillcrest Hospital Cancer CenterRecruiting
Mayfield Heights, Ohio, United States
Consultants in Medical Oncology and HematologyRecruiting
Broomall, Pennsylvania, United States
Alliance Cancer SpecialistsRecruiting
Media, Pennsylvania, United States
Allegheny General HospitalRecruiting
Pittsburgh, Pennsylvania, United States
University of Pittsburgh (UPMC) Hillman Cancer CenterRecruiting
Pittsburgh, Pennsylvania, United States
SCRI OP (Oncology Partners)Recruiting
Nashville, Tennessee, United States
Texas Oncology - Central SouthRecruiting
Austin, Texas, United States
University of Texas Southwestern Medical Center/Clinical Research DepartmentRecruiting
Dallas, Texas, United States
Texas Oncology - West TexasRecruiting
Odessa, Texas, United States
Virginia Cancer SpecialistsRecruiting
Fairfax, Virginia, United States
Uniklinikum Salzburg, Landeskrankenhaus, Universitatsklinik fur Innere Medizin III der PMU Department of Internal Medicine IIIRecruiting
Salzburg, Austria
Medizinische Universitaet Wien - Allgemeines Krankenhaus der Stadt Wien (AKH)Recruiting
Vienna, Austria
Universitair Ziekenhuis AntwerpenRecruiting
Edegem, Belgium
Algemeen Ziekenhuis Sint-LucasRecruiting
Ghent, Belgium
AZ Maria Middelares - Campus AZ Maria MiddelaresRecruiting
Ghent, Belgium
Jessa Ziekenhuis SalvadorRecruiting
Hasselt, Belgium
Universitair Ziekenhuis BrusselRecruiting
Jette, Belgium
AZ GroeningeRecruiting
Kortrijk, Belgium
Vivalia St JosephRecruiting
Libramont, Belgium
Universite Catholique de Louvain Namur, Centre Hospitalier Universitaire Dinant GodinneRecruiting
Yvoir, Belgium
Anhui Provincial HospitalRecruiting
Hefei, Anhui, China
Fujian Cancer HospitalRecruiting
Fuzhou, Fujian, China
The First Affiliated Hospital of Xiamen UniversityRecruiting
Xiamen, Fujian, China
Guangdong Provincial People's HospitalRecruiting
Guangzhou, Guangdong, China
Guangxi Medical University Affiliated Tumor HospitalRecruiting
Naning, Guangxi, China
Harbin Medical University Cancer HospitalRecruiting
Heilongjiang, Harbin, China
Fourth Hospital of Hebei Medical UniversityRecruiting
Shijiazhuang, Hebei, China
The First Affiliated Hospital of Zhengzhou UniversityRecruiting
Zhengzhou, Henan, China
Hubei Cancer HospitalRecruiting
Wuhan, Hubei, China
Hunan Cancer HospitalRecruiting
Changsha, Hunan, China
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical SchoolRecruiting
Nanjing, Jiangsu, China
Jiangxi Cancer HospitalRecruiting
Nanchang, Jiangxi, China
Jilin Cancer HospitalRecruiting
Changchun, Jilin, China
The First Affiliated Hospital of Xi'an Jiaotong UniversityRecruiting
Xi'an, Shaanxi, China
Shandong Cancer HospitalRecruiting
Jinan, Shandong, China
Linyi Cancer HospitalRecruiting
Linyi, Shandong, China
Shanghai Pulmonary HospitalRecruiting
Shanghai, Shanghai Municipality, China
Sichuan Cancer HospitalRecruiting
Chengdu, Sichuan, China
Zhejiang Cancer HospitalRecruiting
Hangzhou, Zhejiang, China
Taizhou Hospital of Zhejiang ProvinceRecruiting
Taizhou, Zhejiang, China
Cancer Hospital Chinese Academy of Medical SciencesRecruiting
Beijing, China
Beijing Cancer HospitalRecruiting
Beijing, China
Henan cancer HospitalRecruiting
Zhengzhou, China
Nemocnice HoroviceRecruiting
Hořovice, Czechia
Nemocnice AGEL Ostrava-Vitkovice a. s.Recruiting
Vítkovice, Czechia
Institut Sainte CatherineRecruiting
Avignon, France
Hospices Civils de Lyon - Hopital Louis PradelRecruiting
Bron, France
Centre Hospitalier Intercommunal de Creteil (CHIC) - Centre de ressources et de competences pour la mucoviscidose (C.R.C.M.)Recruiting
Créteil, France
Centre Hospitalier - Le MansRecruiting
Le Mans, France
Centre Hospitalier Universitaire (CHU) De Limoges Hopital DupuytrenRecruiting
Limoges, France
Centre Leon-Berard (CLB) - Centre de Recherche en Cancerologie Lyon-EstRecruiting
Lyon, France
Centre de Recherche Clinique Hôpital de la Croix-RousseRecruiting
Lyon, France
Centre Hospitalier Regional Universitaire (CHRU) Montpellier Arnaud de VilleneuveRecruiting
Montpellier, France
Centre Hospitalier Lyon-Sud, CHLSRecruiting
Pierre-Bénite, France
Centre Hospitalier de Cornouaille - Hopital LaennecRecruiting
Quimper, France
Hopital Nord Guillaume-et-Rene-Laennec CHU de NantesRecruiting
Saint-Herblain, France
Hopital FochRecruiting
Suresnes, France
Centre Hospitalier Intercommunal Toulon La Seyne Sur Mer (C.H.I.T.S) - Hospital Font-PreRecruiting
Toulon, France
Clinique TeissierRecruiting
Valenciennes, France
Klinikum der Johann Wolfgang Goethe-UniversitätRecruiting
Frankfurt am Main, Hesse, Germany
Evangelische Lungenklinik BerlinRecruiting
Berlin, Germany
Krankenhaus Koeln-MerheimRecruiting
Cologne, Germany
University Hospital Carl Gustav CarusRecruiting
Dresden, Germany
Krankenhaus Martha-Maria Halle-Doelau gGmbHRecruiting
Halle, Germany
Studiengesellschaft Haemato-Onkologie Hamburg, Prof. Laack und PartnerRecruiting
Hamburg, Germany
Sotiria General Hospital of AthensRecruiting
Athens, Greece
University General Hospital of PatrasRecruiting
Rio, Greece
NOSILEFTIKI A.E. - Saint Luke's ClinicRecruiting
Thessaloniki, Greece
European Interbalkan Medical CenterRecruiting
Thessaloniki, Greece
Iatriko Diavalkaniko ThessalonikisRecruiting
Thessaloniki, Greece
Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto IRecruiting
Ancona, Italy
FPO IRCCS CandioloRecruiting
Candiolo, Italy
IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori"(IRST)Recruiting
Meldola, Italy
AUSL Della Romagna - Ospedale S.Maria delle CrociRecruiting
Ravenna, Italy
Istituti Fisioterapici Ospitalieri (IFO) - Istituto Nazionale Tumori Regina Elena (IRE) UO Oncologia Ospedali Civili di LivornoRecruiting
Roma, Italy
Centro Ricerche Cliniche di Verona s.r.l.Recruiting
Verona, Italy
Kurume University HospitalRecruiting
Kurume, Fukuoka, Japan
Asahikawa Medical University HospitalRecruiting
Asahikawa, Hokkaido, Japan
KKR Sapporo Medical CenterRecruiting
Sapporo, Hokkaido, Japan
Kanagawa Cancer CenterRecruiting
Yokohama, Kanagawa, Japan
Sendai Kousei HospitalRecruiting
Sendai, Miyagi, Japan
Shinshu University HospitalRecruiting
Matsumoto, Nagano, Japan
National Hospital Organization Nagasaki Medical CenterRecruiting
Ōmura, Nagasaki, Japan
Nara Medical University HospitalRecruiting
Kashihara, Nara, Japan
Kansai Medical University HospitalRecruiting
Hirakata, Osaka, Japan
Izumi City General HospitalRecruiting
Izumi, Osaka, Japan
Kinki Chuo Chest Medical CenterRecruiting
Sakai, Osaka, Japan
Dokkyo Medical University Saitama Medical CenterRecruiting
Koshigaya, Saitama, Japan
Shizuoka Cancer CenterRecruiting
Shizuoka, Sunto-gun, Japan
Dokkyo Medical University HospitalRecruiting
Shimosuga, Tochigi, Japan
Nippon Medical School HospitalRecruiting
Bunkyō-Ku, Tokyo, Japan
Komagome HospitalRecruiting
Bunkyō-Ku, Tokyo, Japan
The Cancer Institute Hospital of JFCRRecruiting
Koto-Ku, Tokyo, Japan
National Center for Global Health and MedicineRecruiting
Shinjuku-Ku, Tokyo, Japan
Kyushu Medical CenterRecruiting
Fukuoka, Japan
Kyushu University HospitalRecruiting
Fukuoka, Japan
Hiroshima University HospitalRecruiting
Hiroshima, Japan
National Cancer Center Hospital EastRecruiting
Kashiwa, Japan
Osaka International Cancer InstituteRecruiting
Osaka, Japan
Amphia ZiekenhuisRecruiting
Breda, Netherlands
Tergooi ZiekenhuizenRecruiting
Hilversum, Netherlands
Instytut MSF Sp. z o.o.Recruiting
Lodz, Poland
Pratia S.A. , Pratia PoznanRecruiting
Poznan, Poland
Med-Polonia Sp. z o.o.Recruiting
Poznan, Poland
Wojewodzki Szpital im. Sw. Ojca Pio w PrzemysluRecruiting
Przemyśl, Poland
Wojskowy Instytut Medyczny,Centralny Szpital Kliniczny Ministerstwa Obronty NarodowejRecruiting
Siedlce, Poland
Wojskowy Instytut MedycznyRecruiting
Warsaw, Poland
UOMI Cancer Center-Clinica Tres TorresRecruiting
Barcelona, Spain
Hospital Clinic de Barcelona (Hospital Clinic i Provincial)Recruiting
Barcelona, Spain
Hospital General Universitario de ElcheRecruiting
Elche, Spain
Institut Catala d'Oncologia GIRONARecruiting
Girona, Spain
Hospital Universitario de JerezRecruiting
Jerez de la Frontera, Spain
Hospital Universitario Ramon y CajalRecruiting
Madrid, Spain
Hospital Universitario La PazRecruiting
Madrid, Spain
Clinica Universidad de Navarra - MadridRecruiting
Madrid, Spain
Hospital Quironsalud MalagaRecruiting
Málaga, Spain
Universidad de Navarra - Clínica Universidad de Navarra (CUN)Recruiting
Pamplona, Spain
Hospital Universitari Sant Joan De Reus, S.ARecruiting
Reus, Spain
Hospital Universitario Virgen Macarena / Clinical Research DepartmentRecruiting
Seville, Spain
Hospital Universitario Virgen del RocioRecruiting
Seville, Spain
Fundación Instituto Valenciano de OncologíaRecruiting
Valencia, Spain
Memorial Ankara HospitalRecruiting
Çankaya, Ankara, Turkey (Türkiye)
Istanbul University Cerrahpasa Faculty of Medicine HospitalRecruiting
Fatih, Istanbul, Turkey (Türkiye)
Istanbul Medeniyet University Medical FacultyRecruiting
Kadıköy, Istanbul, Turkey (Türkiye)
Medical Park Seyhan HospitalRecruiting
Adana, Turkey (Türkiye)
Baskent University Adana Turgut Noyan Application and Research Center Kisla Health CampusRecruiting
Adana, Turkey (Türkiye)
Liv Hospital AnkaraRecruiting
Ankara, Turkey (Türkiye)
Ankara Bilkent City HospitalRecruiting
Ankara, Turkey (Türkiye)
Medical Park Florya HospitalRecruiting
Istanbul, Turkey (Türkiye)
Yeditepe University HospitalRecruiting
Istanbul, Turkey (Türkiye)
Sakarya University - Faculty of MedicineRecruiting
Sakarya, Turkey (Türkiye)
Addenbrooke's Hospital - Cambridge University Hospitals NHS Foundation TrustRecruiting
Cambridge, Cambridgeshire, United Kingdom
Sarah Cannon Research InstituteRecruiting
London, Greater London, United Kingdom
Royal Marsden Hospital (RMH) - Royal Marsden NHS Foundation TrustRecruiting
Chelsea, London, United Kingdom
Royal Marsden Hospital (Sutton) - Royal Marsden NHS Foundation TrusRecruiting
Sutton, London, United Kingdom
Royal Stoke University Hospital - University Hospitals of North Midlands NHS TrustRecruiting
Stoke-on-Trent, Staffordshire, United Kingdom
Nottingham University Hospitals NHS Trust - Nottingham City HospitalRecruiting
Nottingham, United Kingdom
New Cross HospitalRecruiting
Wolverhampton, United Kingdom